Serum sPD‐1 and sPD‐L1 as predictive biomarkers for HBsAg clearance in HBeAg‐negative CHB patients undergoing IFN‐based therapy

Ähnliche Einträge

• Letter: Muddle of serum sPD‐1 and sPD‐L1 levels and association with HBsAg clearance in HBeAg‐negative CHB patients on IFN therapy
  von: Ankur Jindal
  Veröffentlicht: (2024)
• Virological and Immunological Characteristics of HBeAg ‐Positive Chronic Hepatitis B Patients With Low HBsAg Levels
  von: Yuxin Chen, et al.
  Veröffentlicht: (2024)
• Higher end‐of‐treatment HBsAg levels is associated with later onset but not severe relapse in HBeAg‐negative chronic hepatitis B patients stopping antivirals
  von: Yen‐Chun Liu, et al.
  Veröffentlicht: (2024)
• Favourable Prognosis of Patients With Untreated HBeAg‐Negative Chronic Hepatitis B Virus Infection With HBsAg < 100 IU/mL
  von: Jian Wang, et al.
  Veröffentlicht: (2024)
• Editorial: HBeAg ‐Positive Chronic Hepatitis B With Low HBsAg Levels—Exploring Clinical Significance of preS2 Deletion Mutations
  von: Ying‐Nan Tsai, et al.
  Veröffentlicht: (2025)